
| 2020 | |
|---|---|
| Criterium: | Position: |
| Overall Score: | > 1000 |
| Total Project Funding per Partner: | > 1000 |
| Total Number of Projects: | > 1000 |
Total number of projects: 2
As coordinator: 0
As participant: 2
Sole participant: 0
Coordinator / Participant Ratio: 0*
| Total project funding [€]: | Projects [No]: | |||||
|---|---|---|---|---|---|---|
| Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
| 2021 | 0 | 18.600.000 | 387.589 | 1 | ||
| 2020 | 0 | 3.034.581 | 131.625 | 1 | ||
Total number of partners: 47
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 47
Frequent / Rare Partner Ratio: 0
| Start date | Project | acronym | role | funding | partners |
|---|---|---|---|---|---|
| 2021-09-01 | Innovations to accelerate vaccine development and manufacture | Inno4Vac | participant | 18.600.000 | 41 |
| 2020-03-01 | Monoclonal Antibodies against 2019-New Coronavirus | MANCO | participant | 3.034.581 | 8 |